TIS tissue therapies limited

As I understand it the EMA asked for a delay in their process...

  1. 4,013 Posts.
    lightbulb Created with Sketch. 2069
    As I understand it the EMA asked for a delay in their process due to workload and Christmas but they also brought forward some questions that would normally answered after approval. If they weren't fairly happy with what the answers that TIS had provided in the past and that they were going to be ready to approve Vitrogrow after this round then surely they wouldn't have asked for the post approval questions as well?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.